CIK 0001750284 · Non-accelerated filer<br>Smaller reporting company
Olema Oncology, Inc.
Sign in to watch- Ticker
- OLMA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 300409740
- Phone
- (415) 651-3316
- Business address
- 365 OYSTER POINT BOULEVARD, SUITE 400, SOUTH SAN FRANCISCO, CA, 94080
- Former names
- Olema Pharmaceuticals, Inc.
- 4 Open-market sale CH. DISCOV. & NON-CLIN DEV OFF sold 26,066 shares at an average $9.01 ($234,916)
- 4 Open-market sale CHIEF MEDICAL OFFICER sold 27,805 shares at an average $9.01 ($250,456)
- 4 Open-market sale CH. OPERATING & FINANCIAL OFF. sold 35,159 shares at an average $9.01 ($316,703)
- 4 Open-market sale PRESIDENT AND CEO sold 109,502 shares at an average $9.01 ($986,365)
- 4 Returned to the company Director returned 3,369,704 shares (to the company)
- 4/A Open-market sale Director sold 1,175,000 shares at $14.85 ($17,448,750)
- 4 Option exercise Ch. Operating & Financial Off. acquired 25,000 shares (option exercise)
- 4 Open-market sale 10% owner sold 2,400,000 shares at $14.92 ($35,796,000)
- 4 Planned sale Director sold 5,000 shares at an average $15.57 ($77,872)
- 4 Planned sale Director sold 5,000 shares at $12.26 ($61,300)
- 4 Planned sale Director sold 20,000 shares at $10.77 ($215,400)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 4 of 13 · 244 filings